[Table/Fig-5]:
Results of antibiotic susceptibility testing by disk diffusion showing isolates susceptible to various antibiotics. (n=491).
| ANTIBIOTIC (disk content in μg) |
E.coli No. of sensitive isolates (%) (n=275) |
Klebsiella pneumoniae No. of sensitive isolates (%) (n=216) |
||
|---|---|---|---|---|
| Wards (224) | ICUs (51) | Wards (150) | ICUs (66) | |
| Meropenem (10) | 191 (85.3) | 27 (52.9) | 124 (82.7) | 32 (48.5) |
| Imipenem (10) | 172 (76.8) | 21 (41.2) | 119 (79.3) | 31 (46.9) |
| Ertapenem (10) | 160 (71.4) | 16 (31.4) | 103 (68.7) | 26 (39.4) |
| Amikacin (30) | 140 (62.5) | 29 (56.8) | 83 (55.3) | 25 (37.8) |
| Gentamycin (10) | 121 (54) | 26 (51) | 62 (41.43) | 17 (25.8) |
| Tobramycin (10) | 116 (51.8) | 14 (27.4) | 70 (46.7) | 18 (27.3) |
| Netilmycin (30) | 111 (49.6) | 16 (31.4) | 71 (47.3) | 15 (22.7) |
| Ciprofloxacin (5) | 37 (16.5) | 6 (11.8) | 48 (32) | 13 (19.7) |
| Levofloxacin (5) | 41 (18.3) | 8 (15.6) | 60 (40) | 16 (24.2) |
| Ceftriaxone (30) | 35 (15.6) | 4 (7.8) | 28 (18.6) | 7 (10.6) |
| Cefepime (30) | 37 (16.5) | 6 (11.8) | 41 (27.3) | 16 (24.2) |
| Piperacillin/tazobactam (100/10) |
96 (42.8) | 11 (21.6) | 62 (41.3) | 18 (27.3) |
| Ticarcillin-clavulanate (75/10) |
73 (32.6) | 8 (15.7) | 59 (39.3) | 23 (34.8) |
| Doxycycline (30) | 77 (34.4) | 20 (39.2) | 68 (45.3) | 25 (37.9) |
| Tigecycline (15) | 219 (97.8) | 49 (96.1) | 143 (95.3) | 60 (90.9) |
| Colistin (Etest MIC) | 224 (100) | 50 (98) | 147 (98) | 62 (93.9) |